Pharma Journalist - Page 875 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

CytoDyn’s PRO 140 treats patient suffering from GvHD in Phase 2 trial

FDA approves Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market

Dr. Donna Morgan Murray appointed as Nativis Chief Regulatory Officer

Russian Federation approves multi-dosage cGMP certificate to Saneca Pharma

SystImmune selects MilliporeSigma’s CHOZN Expression System for Bi-specific Antibody Development

AVEO Oncology appoints Matthew Dallas as CFO

Cambrex Invests $2.4M to increase Pilot Scale Capacity at its High Point facility

Halo Pharma announces the Formation of its Pediatric Center of Excellence

BMS and Calithera Biosciences expand collaboration to evaluate Opdivo combined with CB-839 on NSCLC Patients

Noxxon Pharma signs collaboration with NCT in Heidelberg